Yesterday’s article on the astounding size and growth of the 340B Drug Pricing Program generated a lot of controversy. ICYMI: The 340B Program Hits $16.2 Billion in 2016; Now 5% of U.S. Drug Market
Today, I provide some context by showing how the program has taken over the hospital market.
Most 340B purchases are made by hospitals. My exclusive number-crunching below reveals that hospitals now receive discounted 340B pricing on more than 50% of their drug purchases.
Curiously, the value of hospitals' uncompensated care has been declining while 340B purchases have been soaring.
Enjoy!
Read more »
Source: Post feed
